Alzheimer's disease (AD) is a stealthy and progressive neurological disorder that is a leading cause of dementia in the global elderly population, imposing a significant burden on both the elderly and society. Currently, the condition is treated with medications that alleviate symptoms. Nonetheless, these drugs may not consistently produce the desired results and can cause serious side effects. Hence, there is a vigorous pursuit of alternative options to enhance the quality of life for patients. Ginkgo biloba (GB), an herb with historical use in traditional medicine, contains bioactive compounds such as terpenoids (Ginkgolides A, B, and C), polyphenols, organic acids, and flavonoids (quercetin, kaempferol, and isorhamnetin). These compounds are associated with anti-inflammatory, antioxidant, and neuroprotective properties, making them valuable for cognitive health. A systematic search across three databases using specific keywords GB in AD and dementia yielded 1702 documents, leading to the selection of 15 clinical trials for synthesis. In eleven studies, GB extract/EGb 761® was shown to improve cognitive function, neuropsychiatric symptoms, and functional abilities in both dementia types. In four studies, however, there were no significant differences between the GB-treated and placebo groups. Significant improvements were observed in scores obtained from the Mini-Mental State Examination (MMSE), Short Cognitive Performance Test (SKT), and Neuropsychiatric Inventory (NPI). While the majority of synthesized clinical trials show Ginkgo biloba has promising potential in these conditions, more research is needed to determine optimal dosages, effective delivery methods, and appropriate pharmaceutical formulations. Furthermore, a thorough assessment of adverse effects, exploration of long-term use implications, and investigation into potential drug interactions are critical aspects that must be carefully evaluated in future studies.

In this paper, we present some new models for anisotropic compact stars within the framework of 5-dimensional Einstein-Gauss-Bonnet (EGB) gravity with a linear and nonlinear equation of state considering a metric potential proposed for Thirukkanesh and Ragel (2012) and generalized for Malaver (2014). The new obtained models satisfy all physical requirements of a physically reasonable stellar object. Variables as energy density, radial pressure and the anisotropy are dependent of the values of the Gauss-Bonnet coupling constant

In this work, we investigated whether the Pseudo-Newtonian theory (PNP) is applicable to black hole solution in modified gravity. In this regard, as an example, a static spherically symmetric 4D AdS Schwarzschild Yang-Mills black hole in EinsteinGauss-Bonnet gravity is considered. Also, a brief discussion on the structure and horizons of this black hole spacetime is presented. We calculated angular momentum and energy in the framework of the general theory of relativity as well as in PNP theory. In both of these framework, a graphical comparison of angular momentum has been studied